- Home
- PLAY vs PHAR Comparison
PLAY vs PHAR Comparison
Compare PLAY & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAY
- PHAR
- Stock Information
- Founded
- PLAY 1982
- PHAR 1988
- Country
- PLAY United States
- PHAR Netherlands
- Employees
- PLAY N/A
- PHAR N/A
- Industry
- PLAY Restaurants
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- PLAY Consumer Discretionary
- PHAR Health Care
- Exchange
- PLAY Nasdaq
- PHAR Nasdaq
- Market Cap
- PLAY 887.6M
- PHAR 938.6M
- IPO Year
- PLAY 1995
- PHAR N/A
- Fundamental
- Price
- PLAY $24.20
- PHAR $14.87
- Analyst Decision
- PLAY Hold
- PHAR Strong Buy
- Analyst Count
- PLAY 8
- PHAR 3
- Target Price
- PLAY $31.50
- PHAR $30.00
- AVG Volume (30 Days)
- PLAY 757.0K
- PHAR 11.4K
- Earning Date
- PLAY 09-15-2025
- PHAR 10-23-2025
- Dividend Yield
- PLAY N/A
- PHAR N/A
- EPS Growth
- PLAY N/A
- PHAR N/A
- EPS
- PLAY 1.02
- PHAR N/A
- Revenue
- PLAY $2,112,300,000.00
- PHAR $339,836,000.00
- Revenue This Year
- PLAY $4.00
- PHAR $16.63
- Revenue Next Year
- PLAY $6.58
- PHAR $6.77
- P/E Ratio
- PLAY $23.68
- PHAR N/A
- Revenue Growth
- PLAY N/A
- PHAR 22.44
- 52 Week Low
- PLAY $15.08
- PHAR $6.73
- 52 Week High
- PLAY $43.73
- PHAR $17.08
- Technical
- Relative Strength Index (RSI)
- PLAY 40.77
- PHAR 65.27
- Support Level
- PLAY $24.28
- PHAR $13.60
- Resistance Level
- PLAY $25.25
- PHAR $15.40
- Average True Range (ATR)
- PLAY 1.09
- PHAR 0.68
- MACD
- PLAY 0.11
- PHAR 0.13
- Stochastic Oscillator
- PLAY 26.01
- PHAR 86.37
About PLAY Dave & Buster's Entertainment Inc.
Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.